ISOGENIS
DEAD

Serial Number

76346189

Owner

Isogenis, Inc.

Attorney

Anastasia Khokhryakova

Filing Date

Dec 6, 2001

Add to watchlist:

No watchlists yet
View on USPTO

ISOGENIS Trademark

Serial Number: 76346189

ISOGENIS is a trademark filed by Isogenis, Inc. on December 6, 2001. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Isogenis, Inc. (2 trademarks)

50 South Steele Street
Denver, CO 80209

Entity Type: 03

Trademark Details

Filing Date

December 6, 2001

Registration Date

Not Registered

Published for Opposition

April 8, 2003

Goods & Services

Pharmaceutical, medical and therapeutic products, namely, medicaments, pharmaceutical preparations and gene therapy vectors for the treatment of and use in gene therapy, genetic disorders, auto immune diseases; pharmaceutical, medical and therapeutic products, namely, medicaments, pharmaceutical preparations and gene therapy vectors for the treatment of and use in stem cell transplantation for humans, tissue and organ transplantation, namely, prevention of transplant rejection; auxiliary preparations, carriers and substances sold as integral components of pharmaceutical preparations and gene therapy vectors

Chemical, biological and bioengineering reagents, protein receptors, gene therapy vectors, chemical preparations in the form of receptors, DNA sequences, DNA variations, and cells, all used for scientific, laboratory or medical research in the fields of gene therapy, genetic disorders, genetic engineering and bioengineering, auto immune diseases, stem cell research, tissue and organ transplantation, namely, prevention of transplant rejection; biological preparations, namely, recombinant vectors for laboratories, diagnostics, and analytics for scientific or research use; auxiliary preparations, carriers and substances for use in the manufacture of pharmaceutical preparations

Medical and scientific research and product research all in the field of gene therapy, genetic disorders, auto immune diseases, stem cell and organ transplantation, namely, prevention of transplant rejection

Filing History

ABANDONMENT - NO USE STATEMENT FILED
Sep 16, 2004 ABN6
CASE FILE IN TICRS
Aug 13, 2004 CFIT
SOU EXTENSION 1 GRANTED
Jan 16, 2004 EX1G
SOU EXTENSION 1 FILED
Dec 11, 2003 EXT1
PAPER RECEIVED
Dec 11, 2003 MAIL
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jul 1, 2003 NOAM
PUBLISHED FOR OPPOSITION
Apr 8, 2003 PUBO
NOTICE OF PUBLICATION
Mar 19, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 24, 2003 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 13, 2002 CRFA
FINAL REFUSAL MAILED
Jun 24, 2002 CNFR
NON-FINAL ACTION MAILED
Feb 21, 2002 CNRT
ASSIGNED TO EXAMINER
Feb 20, 2002 DOCK
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2002 CRFA